title: Attention deficit hyperactivity disorder (ADHD)--life insurance implications.
abstract: Attention deficit hyperactivity disorder (ADHD) is the most common neurobehavioral disorder in youth. About one-half of these youngsters continue to have symptoms as they enter their 20s. Of these, some also have co-morbid conditions such as conduct disorders, psychiatric problems and substance abuse. The medical director must be able to recognize the small subset of affected individuals whose mortality due to ADHD is greater than that of the standard population.
authors.affiliation: Amerus Life Insurance Group. jack.cotlar@indianapolislife.com
authors.forename: M Jack
authors.initials: MJ
authors.lastname: Cotlar
mesh_terms: D000206:Actuarial Analysis; D000293:Adolescent; D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000175:diagnosis / Q000191:economics* / Q000401:mortality; D016642:Bupropion / Q000627:therapeutic use; D015897:Comorbidity; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007352:Insurance, Life; D008297:Male; D019982:Organizational Case Studies; D018570:Risk Assessment
chemical_list: D018687:Antidepressive Agents, Second-Generation; D016642:Bupropion